| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of neuromyelitis optica spectrum disorder following seasonal influenza vaccination
|
Cho, Jeong Hee
|
|
|
30 |
C |
p. 110-113
|
artikel
|
| 2 |
Alemtuzumab as rescue therapy in case of multiple sclerosis rebound following Natalizumab break: Clinical case and literature review
|
Federle, Lisa
|
|
|
30 |
C |
p. 262-264
|
artikel
|
| 3 |
Aquaporin-4 antibody positive short transverse myelitis associated with breast cancer
|
Liao, Weijing
|
|
|
30 |
C |
p. 119-122
|
artikel
|
| 4 |
Assessing the effects of post-acute rehabilitation services on health care outcomes for people with multiple sclerosis
|
Zhang, Tingting
|
|
|
30 |
C |
p. 277-283
|
artikel
|
| 5 |
Associations of demographic and clinical factors with depression over 2.5-years in an international prospective cohort of people living with MS
|
Simpson Jr., Steve
|
|
|
30 |
C |
p. 165-175
|
artikel
|
| 6 |
Barriers against a successful MS treatment: The importance of effectiveness beyond efficacy
|
Alonso, Ricardo
|
|
|
30 |
C |
p. 129-135
|
artikel
|
| 7 |
Changes in patient-reported outcomes between continuers and discontinuers of disease modifying therapy in patients with multiple sclerosis over age 60
|
Hua, Le H.
|
|
|
30 |
C |
p. 252-256
|
artikel
|
| 8 |
Clinical and MRI correlates of CSF neurofilament light chain levels in relapsing and progressive MS
|
Damasceno, Alfredo
|
|
|
30 |
C |
p. 149-153
|
artikel
|
| 9 |
Clinical characteristics of myelin oligodendrocyte glycoprotein antibody neuromyelitis optica spectrum disorder
|
Salama, Sara
|
|
|
30 |
C |
p. 231-235
|
artikel
|
| 10 |
Clinical correlates of 9-hole peg test in a large population of people with multiple sclerosis
|
Solaro, Claudio
|
|
|
30 |
C |
p. 1-8
|
artikel
|
| 11 |
Clinical course of neuromyelitis optica spectrum disorder in a moroccan cohort
|
Bennis, Anas
|
|
|
30 |
C |
p. 141-148
|
artikel
|
| 12 |
Clinical, neuroimaging and therapeutic response in AQP4-positive NMO patients from India
|
Netravathi, M.
|
|
|
30 |
C |
p. 85-93
|
artikel
|
| 13 |
Cognitive speed and white matter integrity in secondary progressive multiple sclerosis
|
Manca, Riccardo
|
|
|
30 |
C |
p. 198-207
|
artikel
|
| 14 |
Corrigendum to: “A case of Takotsubo syndrome during a multiple sclerosis brainstem relapse” [Mult. Scler. Relat. Disord. 24 (2018) 1–2]
|
Prestipino, Elio
|
|
|
30 |
C |
p. 292
|
artikel
|
| 15 |
Corrigendum to “Changes in patient-reported outcomes between continuers and discontinuers of disease modifying therapy in patients with multiple sclerosis over age 60” [Multiple Sclerosis and Related Disorders 30 (2019) 252–256]
|
Hua, Le H.
|
|
|
30 |
C |
p. 293
|
artikel
|
| 16 |
Corrigendum to “Foxp3+ regulatory T cells expression in Neuromyelitis optica spectrum disorders” [Multiple Sclerosis and Related Disorders 30 (2019) 114–118]
|
Brill, Livnat
|
|
|
30 |
C |
p. 291
|
artikel
|
| 17 |
Depressive symptoms and fatigue as predictors of objective-subjective discrepancies in cognitive function in multiple sclerosis
|
Hughes, Abbey J.
|
|
|
30 |
C |
p. 192-197
|
artikel
|
| 18 |
Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis
|
Yalachkov, Yavor
|
|
|
30 |
C |
p. 33-37
|
artikel
|
| 19 |
Differential multiple sclerosis treatment allocation between Australia and New Zealand associated with clinical outcomes but not mood or quality of life
|
Phyo, Aung Zaw Zaw
|
|
|
30 |
C |
p. 25-32
|
artikel
|
| 20 |
Disease modifying therapies continue to drive up health care cost among individuals with multiple sclerosis
|
Kim, Youngran
|
|
|
30 |
C |
p. 69-75
|
artikel
|
| 21 |
Does cognitive reserve play any role in multiple sclerosis? A meta-analytic study
|
Santangelo, Gabriella
|
|
|
30 |
C |
p. 265-276
|
artikel
|
| 22 |
Efficacy and safety of alemtuzumab in Korean multiple sclerosis patients
|
Kim, Hyunjin
|
|
|
30 |
C |
p. 247-251
|
artikel
|
| 23 |
Erdheim–Chester disease mimicking multiple sclerosis or a new association?
|
Sánchez-Villalobos, José Manuel
|
|
|
30 |
C |
p. 94-97
|
artikel
|
| 24 |
Foxp3+ regulatory T cells expression in neuromyelitis optica spectrum disorders
|
Brill, Livnat
|
|
|
30 |
C |
p. 114-118
|
artikel
|
| 25 |
Highly active multiple sclerosis: An update
|
Díaz, Cindy
|
|
|
30 |
C |
p. 215-224
|
artikel
|
| 26 |
Hypocomplementemic urticarial vasculitis and multiple Sclerosis: A rare association or an atypical presentation?
|
Durães, João
|
|
|
30 |
C |
p. 244-246
|
artikel
|
| 27 |
Incidence of multiple sclerosis misdiagnosis in referrals to two academic centers
|
Kaisey, Marwa
|
|
|
30 |
C |
p. 51-56
|
artikel
|
| 28 |
Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease
|
Peng, Lijun
|
|
|
30 |
C |
p. 123-128
|
artikel
|
| 29 |
Increased level of plasma salusin-α and salusin-β in patients with multiple sclerosis
|
Çakır, Murat
|
|
|
30 |
C |
p. 76-80
|
artikel
|
| 30 |
Intra-family phenotype variations in familial neuromyelitis optica spectrum disorders
|
Lee, Jun-Jun
|
|
|
30 |
C |
p. 57-62
|
artikel
|
| 31 |
Isolated recurrent myelitis in a persistent MOG positive patient
|
Anis, S.
|
|
|
30 |
C |
p. 163-164
|
artikel
|
| 32 |
Kappa free light chains could predict early disease course in multiple sclerosis
|
Vecchio, D.
|
|
|
30 |
C |
p. 81-84
|
artikel
|
| 33 |
Misdiagnosis of multiple sclerosis in a female heterozygote with Fabry's disease
|
Berger, Joseph R.
|
|
|
30 |
C |
p. 45-47
|
artikel
|
| 34 |
MOG antibody disease manifesting as progressive cognitive deterioration and behavioral changes with primary central nervous system vasculitis
|
Baba, Toshikazu
|
|
|
30 |
C |
p. 48-50
|
artikel
|
| 35 |
New onset transverse myelitis diagnostic accuracy and patient experiences
|
Greenberg, Benjamin M.
|
|
|
30 |
C |
p. 42-44
|
artikel
|
| 36 |
Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies
|
Mayer, Lori
|
|
|
30 |
C |
p. 236-243
|
artikel
|
| 37 |
Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis
|
Suanprasert, Narupat
|
|
|
30 |
C |
p. 284-290
|
artikel
|
| 38 |
Potential mechanisms of action related to the efficacy and safety of cladribine
|
Baker, David
|
|
|
30 |
C |
p. 176-186
|
artikel
|
| 39 |
Prognostic factors of disability in relapsing remitting multiple sclerosis
|
Briggs, Farren B.S.
|
|
|
30 |
C |
p. 9-16
|
artikel
|
| 40 |
Protective stepping in multiple sclerosis: Impacts of a single session of in-place perturbation practice
|
Van Liew, Charles
|
|
|
30 |
C |
p. 17-24
|
artikel
|
| 41 |
Repetitive intrathecal injection of human NMO-IgG with complement exacerbates disease severity with NMO pathology in experimental allergic encephalomyelitis mice
|
Lee, Chao-Lin
|
|
|
30 |
C |
p. 225-230
|
artikel
|
| 42 |
Saccadic eye movements are able to reduce body sway in mildly-affected people with Multiple Sclerosis
|
Santinelli, Felipe Balistieri
|
|
|
30 |
C |
p. 63-68
|
artikel
|
| 43 |
SFX-01 reduces residual disability after experimental autoimmune encephalomyelitis
|
Galea, Ian
|
|
|
30 |
C |
p. 257-261
|
artikel
|
| 44 |
Suspected bacterial meningoencephalomyelitis as the trigger or presentation of neuromyelitis optica spectrum disorder flare
|
He, Mianwang
|
|
|
30 |
C |
p. 38-41
|
artikel
|
| 45 |
The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findings
|
Kolcava, Jan
|
|
|
30 |
C |
p. 187-191
|
artikel
|
| 46 |
Three suggestions to decrease the financial burden of MS treatments
|
Waubant, Emmanuelle
|
|
|
30 |
C |
p. A1
|
artikel
|
| 47 |
Time between expanded disability status scale (EDSS) scores
|
Zurawski, Jonathan
|
|
|
30 |
C |
p. 98-103
|
artikel
|
| 48 |
Tolerability, treatment satisfaction and quality of life outcomes in stable multiple sclerosis patients switched from injectable therapies to auto injected intramuscular interferon beta 1a: The SFERA study
|
Zecca, Chiara
|
|
|
30 |
C |
p. 104-109
|
artikel
|
| 49 |
Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement
|
Bhargava, Pavan
|
|
|
30 |
C |
p. 136-140
|
artikel
|
| 50 |
Validation of the Brazilian version of the patient-determined disease steps scale in persons with multiple sclerosis
|
de David, Ana C.
|
|
|
30 |
C |
p. 208-214
|
artikel
|
| 51 |
Validity of a multi-domain computerized cognitive assessment battery for patients with multiple sclerosis
|
Golan, Daniel
|
|
|
30 |
C |
p. 154-162
|
artikel
|
Tijdschrift beschrijving